Red cell transfusion has an important role in the management of sickle cell disease (SCD) in both emergency and elective settings. However, because of insufficient randomised data, it is not always clear when or how to use red cell transfusion. A companion guideline, Guidelines on red cell transfusion in sickle cell disease Part I: principles and laboratory aspects, addresses the general principles of transfusion practice in SCD (Davis et al, 2016, BJH in press). The present guideline examines current available evidence on indications for transfusion in SCD. This may not be appropriate for all clinical scenarios and clinical decisions must be based on individual patient considerations. In both guidelines, the term sickle cell disease ref...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
OBJECTIVES: To present the recommendations and supporting evidence for RBC transfusions in criticall...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
Blood transfusions are sometimes required, most usually to treat severe anaemia, in patients with si...
This is a review of the literature as regards the indications for blood transfusion in SCD, complica...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
The following recommendations, which aim at standardising and rationalising clinical indications for...
Blood component transfusion is a frequently prescribed intervention in healthcare that depends on th...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due...
Background: Sickle cell disease is a very common hemoglobinopathy. The main goal of transfusion ther...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
OBJECTIVES: To present the recommendations and supporting evidence for RBC transfusions in criticall...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
BACKGROUND: Red blood cell (RBC) transfusions remain essential in the treatment of patients with sic...
Blood transfusions are sometimes required, most usually to treat severe anaemia, in patients with si...
This is a review of the literature as regards the indications for blood transfusion in SCD, complica...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
Background: Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease...
The following recommendations, which aim at standardising and rationalising clinical indications for...
Blood component transfusion is a frequently prescribed intervention in healthcare that depends on th...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due...
Background: Sickle cell disease is a very common hemoglobinopathy. The main goal of transfusion ther...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
Background Sickle cell disease is one of the commonest severe monogenic disorders in the world, due ...
This is the protocol for a review and there is no abstract. The objectives are as follows: To summa...
OBJECTIVES: To present the recommendations and supporting evidence for RBC transfusions in criticall...